IMP: Resolution of the extraordinary shareholders’ meeting
Imexpharm Pharmaceutical Joint Stock Company (IMP: IMEXPHARM) has informed of the extraordinary shareholders’ meeting as follows:
Article 1: Passing transforming the Remedica one-member limited company into the joint stock company and selling partial capital of IMEXPHARM
Article 2: Passing withdrawal of the business activity as property trade in order to focus on the core business of IMEXPHARM
Article 3: Authorizing the BOD and Management Board of IMEXPHARM and Remedica to cooperate with a consulting unit to implement the contents of the article 1 and 2 in the resolution
Article 4: The resolution is valid from 1st September 2009
hose
> VSC: Viconship to sell treasury stock (11/09/2009)
> BCI: Trading Result (Pham Huynh Phuong Trang) (11/09/2009)
> BCI: Transaction of inside shareholder (Ms. Huong) (11/09/2009)
> DIG: Transaction of affiliated person (11/09/2009)
> FBT: Transaction of inside shareholder (Ms. Nguyen Tuyet Mai) (11/09/2009)
> HAP: Business result in August 2009 (11/09/2009)
> LBM: Transaction of inside shareholder (Mr. Vo Xuan Son) (11/09/2009)
> VIS: Transaction of inside shareholder (Mr. Tran Van Thanh) (11/09/2009)
> LBM: Transaction of inside shareholder (Ms. Dao Thi Tuyet Hanh) (11/09/2009)
> VNL: Business result in the first eight months of 2009 (11/09/2009)